151 related articles for article (PubMed ID: 15025812)
1. Topiramate increases biochemical risk of nephrolithiasis.
Lamb EJ; Stevens PE; Nashef L
Ann Clin Biochem; 2004 Mar; 41(Pt 2):166-9. PubMed ID: 15025812
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and stone-risk profiles with topiramate treatment.
Welch BJ; Graybeal D; Moe OW; Maalouf NM; Sakhaee K
Am J Kidney Dis; 2006 Oct; 48(4):555-63. PubMed ID: 16997051
[TBL] [Abstract][Full Text] [Related]
3. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
4. Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.
Kaplon DM; Penniston KL; Nakada SY
Urology; 2011 Feb; 77(2):295-8. PubMed ID: 20888032
[TBL] [Abstract][Full Text] [Related]
5. Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia.
Jhagroo RA; Wertheim ML; Penniston KL
Br J Clin Pharmacol; 2016 Jan; 81(1):131-6. PubMed ID: 26297809
[TBL] [Abstract][Full Text] [Related]
6. Calcium nephrolithiasis induced by topiramate.
Merino-Salas S; Arrabal-Polo MA; Cano-Garcia Mdel C; Arrabal-Martin M
Arch Esp Urol; 2014 Apr; 67(3):284-7. PubMed ID: 24840594
[TBL] [Abstract][Full Text] [Related]
7. [Citrate and renal stones].
del Valle EE; Spivacow FR; Negri AL
Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
[TBL] [Abstract][Full Text] [Related]
8. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and spot urine risk factors for renal stones in children taking topiramate.
Corbin Bush N; Twombley K; Ahn J; Oliveira C; Arnold S; Maalouf NM; Sakhaee K
J Pediatr Urol; 2013 Dec; 9(6 Pt A):884-9. PubMed ID: 23375465
[TBL] [Abstract][Full Text] [Related]
10. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
[TBL] [Abstract][Full Text] [Related]
11. Induction of progressive profound hypocitraturia with increasing doses of topiramate.
Warner BW; LaGrange CA; Tucker T; Bensalem-Owen M; Pais VM
Urology; 2008 Jul; 72(1):29-32; discussion 32-3. PubMed ID: 18436283
[TBL] [Abstract][Full Text] [Related]
12. Topiramate-induced nephrolithiasis.
Kuo RL; Moran ME; Kim DH; Abrahams HM; White MD; Lingeman JE
J Endourol; 2002 May; 16(4):229-31. PubMed ID: 12042105
[TBL] [Abstract][Full Text] [Related]
13. Increased propensity for calcium phosphate kidney stones with topiramate use.
Vega D; Maalouf NM; Sakhaee K
Expert Opin Drug Saf; 2007 Sep; 6(5):547-57. PubMed ID: 17877442
[TBL] [Abstract][Full Text] [Related]
14. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
15. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
[TBL] [Abstract][Full Text] [Related]
16. Low urinary citrate excretion in nephrolithiasis.
Nicar MJ; Skurla C; Sakhaee K; Pak CY
Urology; 1983 Jan; 21(1):8-14. PubMed ID: 6823713
[TBL] [Abstract][Full Text] [Related]
17. [Migraine-induced kidney stones?].
Gerber L; Wüthrich RP; Mohebbi N
Praxis (Bern 1994); 2012 May; 101(10):665-8. PubMed ID: 22565558
[TBL] [Abstract][Full Text] [Related]
18. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
19. Urinary citrate excretion in patients with renal calculi.
Menon M; Mahle CJ
J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
[TBL] [Abstract][Full Text] [Related]
20. Nephrolithiasis in topiramate users.
Maalouf NM; Langston JP; Van Ness PC; Moe OW; Sakhaee K
Urol Res; 2011 Aug; 39(4):303-7. PubMed ID: 21165738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
